Today: 19 December 2025
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Corcept Therapeutics (CORT) Stock Drops on Dec. 16, 2025: UBS Neutral Call, Relacorilant FDA Catalyst, and Updated Price Targets

Corcept Therapeutics (CORT) Stock Drops on Dec. 16, 2025: UBS Neutral Call, Relacorilant FDA Catalyst, and Updated Price Targets

Corcept Therapeutics Incorporated (NASDAQ: CORT) ended Tuesday, December 16, 2025, sharply lower after a strong 2025 run that had pushed expectations—and valuation—into the spotlight. Shares closed at $79.44, down $7.86 (about 9%) from the prior close, after trading as low
16 December 2025
 ·  ·  ·  ·  · 
Sanmina Stock (SANM) Slumps on Dec. 16, 2025 After Houston Energy Factory Expansion and Končar Transformer Deal

Sanmina Stock (SANM) Slumps on Dec. 16, 2025 After Houston Energy Factory Expansion and Končar Transformer Deal

Sanmina Corporation (NASDAQ: SANM) stock fell sharply in Tuesday trading, even as the company unveiled two growth-oriented moves aimed at the U.S. power-grid equipment market: a new, state-of-the-art energy-focused factory planned for Houston and a transformer co-design agreement with Croatia’s
16 December 2025
 ·  ·  ·  · 
Navan (NAVN) Stock Sinks on Q3 Earnings and CFO Exit: Guidance, Analyst Price Targets, and Forecasts for 2026 (Dec. 16, 2025)

Navan (NAVN) Stock Sinks on Q3 Earnings and CFO Exit: Guidance, Analyst Price Targets, and Forecasts for 2026 (Dec. 16, 2025)

Navan, Inc. (NASDAQ: NAVN) stock was one of the market’s sharpest decliners on Tuesday, December 16, 2025, sliding roughly high-teens after the company’s first post-IPO earnings report landed with a thud—and after investors digested news that the company’s CFO plans
16 December 2025
 ·  ·  ·  ·  · 
Arrowhead Pharmaceuticals (ARWR) Stock Drops on Dec. 16, 2025: Latest News, Analyst Forecasts, and What Investors Are Watching

Arrowhead Pharmaceuticals (ARWR) Stock Drops on Dec. 16, 2025: Latest News, Analyst Forecasts, and What Investors Are Watching

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) is seeing a sharp pullback in Tuesday trading (Dec. 16, 2025), with shares recently changing hands around $62—down roughly 9% from the prior close—after hitting an intraday low near $59.76. That drop may look dramatic
16 December 2025
 ·  ·  ·  ·  · 
Vertex, Inc. (VERX) Stock News Today: Latest Price, AI Tax Automation Updates, Analyst Forecasts and Outlook (Dec. 16, 2025)

Vertex, Inc. (VERX) Stock News Today: Latest Price, AI Tax Automation Updates, Analyst Forecasts and Outlook (Dec. 16, 2025)

Vertex, Inc. (NASDAQ: VERX) — the tax technology company (not Vertex Pharmaceuticals, which trades as VRTX) — is back on investors’ radar on Tuesday, December 16, 2025, as shares trade higher intraday and the market continues to digest a year
16 December 2025
 ·  ·  ·  ·  · 
Comcast Stock (CMCSA) Jumps on Activist Chatter as Versant Spinoff Record Date Arrives — News, Forecasts, and What Investors Are Watching

Comcast Stock (CMCSA) Jumps on Activist Chatter as Versant Spinoff Record Date Arrives — News, Forecasts, and What Investors Are Watching

Comcast Corporation stock (NASDAQ: CMCSA) is in the spotlight on December 16, 2025, with shares rising sharply amid activist-investor speculation and fresh investor focus on the company’s upcoming Versant Media Group spin-off mechanics. As of the latest available market snapshot,
16 December 2025
 ·  ·  ·  · 
Perpetua Resources (PPTA) Stock News Today: Hatch Named EPCM for Stibnite Gold Project, New Private Placement Details, and Updated Analyst Targets (Dec. 16, 2025)

Perpetua Resources (PPTA) Stock News Today: Hatch Named EPCM for Stibnite Gold Project, New Private Placement Details, and Updated Analyst Targets (Dec. 16, 2025)

BOISE, Idaho — December 16, 2025 — Perpetua Resources Corp. (Nasdaq: PPTA / TSX: PPTA) is back in the spotlight today after announcing a major project execution milestone for its flagship Stibnite Gold Project in Idaho: the company has selected
16 December 2025
 ·  ·  ·  · 
Cleveland-Cliffs Stock (NYSE: CLF) on Dec. 16, 2025: Credit Downgrade, Steel Market Shifts, and the 2026 Profitability Debate

Cleveland-Cliffs Stock (NYSE: CLF) on Dec. 16, 2025: Credit Downgrade, Steel Market Shifts, and the 2026 Profitability Debate

Cleveland-Cliffs Inc. (NYSE: CLF) is back in the spotlight on Tuesday, December 16, 2025, as investors weigh a classic “steel-cycle” tug-of-war: improving operating tailwinds versus balance-sheet pressure. In Tuesday’s trading, CLF stock hovered around $12.85, modestly higher on the day,
16 December 2025
 ·  ·  ·  ·  · 
1 … 27 28 29 30 31 … 268
Go toTop